{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:43:04Z","timestamp":1759963384271,"version":"3.33.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1136\/ard.2010.141325","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T00:13:00Z","timestamp":1304899980000},"page":"1507-1510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells"],"prefix":"10.1016","volume":"70","author":[{"given":"Khalid","family":"Muhammad","sequence":"first","affiliation":[]},{"given":"Petra","family":"Roll","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Seibold","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Kleinert","sequence":"additional","affiliation":[]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"D\u00f6rner","sequence":"additional","affiliation":[]},{"given":"Hans-Peter","family":"Tony","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1136\/ard.2010.141325_bib1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar1918","article-title":"Interleukin-6 and rheumatic diseases.","volume":"8","author":"Lipsky","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.141325_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells.","volume":"206","author":"Dienz","year":"2009","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.141325_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.167.2.332","article-title":"The essential role of B cell stimulatory factor 2 (BSF-2\/IL-6) for the terminal differentiation of B cells.","volume":"167","author":"Muraguchi","year":"1988","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.141325_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1385\/CRIAI:28:3:221","article-title":"Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.","volume":"28","author":"Nishimoto","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/ard.2010.141325_bib5","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.","volume":"67","author":"Emery","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.141325_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.25053","volume":"62","author":"Garnero","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.141325_bib7","doi-asserted-by":"crossref","unstructured":"Roll P, Muhammad K, Schumann M, et al. In vivo effect of the anti interleukin-6 receptor inhibitor tocilizumab on the B-cell compartment. Arthritis Rheum. Published Online First: January 18 2011. doi:10.1002\/art.30242.","DOI":"10.1002\/art.30242"},{"key":"10.1136\/ard.2010.141325_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.1998.tb01439.x","article-title":"Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements.","volume":"162","author":"D\u00f6rner","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1136\/ard.2010.141325_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","article-title":"Rationale for interleukin-6 blockade in systemic lupus erythematosus.","volume":"13","author":"Tackey","year":"2004","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.141325_bib10","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u2018memory\u2019 B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard.2010.141325_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2006.02433.x","article-title":"Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.","volume":"119","author":"Liang","year":"2006","journal-title":"Immunology"},{"key":"10.1136\/ard.2010.141325_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clim.2008.09.009","article-title":"Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura.","volume":"130","author":"Martinez-Gamboa","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2010.141325_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4049\/jimmunol.180.1.281","article-title":"Immune complex-bearing follicular dendritic cells deliver a late antigenic signal that promotes somatic hypermutation.","volume":"180","author":"Wu","year":"2008","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.141325_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/intimm\/dxp041","article-title":"IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation.","volume":"21","author":"Wu","year":"2009","journal-title":"Int Immunol"},{"key":"10.1136\/ard.2010.141325_bib15","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3384::AID-IMMU3384>3.0.CO;2-T","article-title":"Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands.","volume":"28","author":"D\u00f6rner","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2010.141325_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature00862","article-title":"AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.","volume":"418","author":"Petersen-Mahrt","year":"2002","journal-title":"Nature"},{"key":"10.1136\/ard.2010.141325_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/clim.2001.5049","article-title":"The role of CD40\u2013CD40 ligand (CD154) interactions in immunoglobulin light chain repertoire generation and somatic mutation.","volume":"100","author":"Monson","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2010.141325_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejphar.2010.02.026","article-title":"Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells.","volume":"634","author":"Yoshida","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1136\/ard.2010.141325_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/art.27359","article-title":"Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment.","volume":"62","author":"Vital","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.141325_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.27221","article-title":"Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.","volume":"62","author":"Illei","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724192102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724192102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.141325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:09:33Z","timestamp":1737248973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724192102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0003496724192102"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.141325","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.141325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}